retatrutide lilly Lilly, with new data, to seek FDA approval of obesity drug 🧬 The biggest retatrutide update

Disclaimer: This product is not designed to diagnose, treat, cure or prevent any condition

What are the main effects and uses

Third, GlP-1 role in myocardial ischemia on three trials showed: a

Together, they address both the structural (collagen matrix) and cellular mobility (actin cytoskeleton) aspects of tissue regeneration

Shares of Eli Lilly and Company (LLY) closed about 2% higher on Monday and edged up after-hours after the company reported that its oral GLP-1 pill Foundayo (orforglipron) outperformed existing treatments on blood sugar control and weight loss in type 2 diabetes patients in three late-stage trials